Anna La Salvia

1.5k total citations
71 papers, 668 citations indexed

About

Anna La Salvia is a scholar working on Oncology, Epidemiology and Neurology. According to data from OpenAlex, Anna La Salvia has authored 71 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Oncology, 45 papers in Epidemiology and 26 papers in Neurology. Recurrent topics in Anna La Salvia's work include Neuroendocrine Tumor Research Advances (45 papers), Lung Cancer Research Studies (38 papers) and Neuroblastoma Research and Treatments (26 papers). Anna La Salvia is often cited by papers focused on Neuroendocrine Tumor Research Advances (45 papers), Lung Cancer Research Studies (38 papers) and Neuroblastoma Research and Treatments (26 papers). Anna La Salvia collaborates with scholars based in Italy, Spain and United States. Anna La Salvia's co-authors include Rocio García‐Carbonero, María Carmen Riesco Martínez, Giorgio V. Scagliotti, Maria Pia Brizzi, Massimo Di Maïo, Antongiulio Faggiano, Nicola Fazio, Elena Trevisi, Roberta Modica and Beatriz Soldevilla and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Journal of Chromatography A.

In The Last Decade

Anna La Salvia

61 papers receiving 664 citations

Peers

Countries citing papers authored by Anna La Salvia

Since Specialization

Citations

This map shows the geographic impact of Anna La Salvia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna La Salvia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna La Salvia more than expected).

Fields of papers citing papers by Anna La Salvia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna La Salvia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna La Salvia. The network helps show where Anna La Salvia may publish in the future.

Co-authorship network of co-authors of Anna La Salvia

This figure shows the co-authorship network connecting the top 25 collaborators of Anna La Salvia. A scholar is included among the top collaborators of Anna La Salvia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna La Salvia. Anna La Salvia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gastroenteropancreatic Neuroendocrine Neoplasms and Celiac Disease: Rare or Neglected Association? 2025 ·Journal of Clinical Medicine ·(unknown), Anna La Salvia, Giovanni Mario Pes, Maria Pina Dore, Giuseppe Fanciulli	1
2	NETest and Gastro-Entero-Pancreatic Neuroendocrine Tumors: Still Far from Routine Clinical Application? A Systematic Review 2025 ·Genes ·Roberta Rossi, Anna La Salvia	1
3	GLP-1 Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways 2025 ·Genes ·(unknown), Stefania Bellino, Anna La Salvia	0
4	Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons 2024 ·Endocrine ·Roberta Modica, Anna La Salvia, Alessia Liccardi, Alessia Cozzolino, Antonella Di Sarno, (unknown), Annamaria Colao, Antongiulio Faggiano, (unknown)	7
5	Predictive Factors of Response to Streptozotocin in Neuroendocrine Pancreatic Neoplasms 2023 ·Journal of Clinical Medicine ·Giuseppe Fanciulli, Anna La Salvia, Sergio Di Molfetta, (unknown), Giulia Puliani, Monica Verrico, Federica Campolo, Annamaria Colao, Antongiulio Faggiano, (unknown)	3
6	MicroRNA signature and integrative omics analyses define prognostic clusters and key pathways driving prognosis in patients with neuroendocrine neoplasms 2023 ·Molecular Oncology ·Beatriz Soldevilla, (unknown), (unknown), (unknown), Sonia Molina‐Pinelo, (unknown), Marta Benavent, (unknown), Marta Fierro‐Fernández, (unknown), Paula Jiménez‐Fonseca, (unknown), (unknown), (unknown), Anna La Salvia, (unknown), (unknown), Rocio García‐Carbonero	2
7	Extrapulmonary Neuroendocrine Carcinomas: Current Management and Future Perspectives 2023 ·Journal of Clinical Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), Maria Grazia Rodriquenz, Luigi Pio Guerrera, Ina Valeria Zurlo, Davide Campana, Maria Pia Brizzi, Mauro Cives, Anna La Salvia, Giuseppe Lamberti	4
8	Metabolomic profile of neuroendocrine tumors identifies methionine, porphyrin, and tryptophan metabolisms as key dysregulated pathways associated with patient survival 2023 ·European Journal of Endocrinology ·Anna La Salvia, (unknown), (unknown), (unknown), Jaume Capdevila, Marta Benavent, Paula Jiménez‐Fonseca, Daniel Castellano, Teresa Alonso, Àlex Teulé, Ana Custodio, Salvatore Tafuto, Adelaida La Casta, Francesca Spada, Ángeles López‐Gonzálvez, (unknown), (unknown), Coral Barbas, Rocio García‐Carbonero, Beatriz Soldevilla	6
9	Chemotherapy in Well Differentiated Neuroendocrine Tumors (NET) G1, G2, and G3: A Narrative Review 2023 ·Journal of Clinical Medicine ·(unknown), (unknown), (unknown), (unknown), Elisa Andrini, Davide Campana, Maria Pia Brizzi, Giuseppe Lamberti, Anna La Salvia	17
10	Molecular Subtypes of Extra-pulmonary Neuroendocrine Carcinomas Identified by the Expression of Neuroendocrine Lineage-Specific Transcription Factors 2022 ·Endocrine Pathology ·Jasna Metović, Anna La Salvia, Ida Rapa, Francesca Napoli, Nadia Birocco, (unknown), Rocio García‐Carbonero, Libero Ciuffreda, Giorgio V. Scagliotti, Mauro Papotti, Marco Volante	17
11	Correction to: Chemotherapy in NEN: still has a role? 2022 ·Reviews in Endocrine and Metabolic Disorders ·(unknown), Anna La Salvia, María Carmen Riesco Martínez, (unknown), Rocio García‐Carbonero	1
12	Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer: Lessons Learned and Future Perspectives 2022 ·Current Treatment Options in Oncology ·María Carmen Riesco Martínez, (unknown), (unknown), Anna La Salvia, Rocio García‐Carbonero	23
13	Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review 2022 ·Seminars in Oncology ·(unknown), (unknown), Anna La Salvia, (unknown), Marco Volante, Consuelo Buttigliero, Giorgio V. Scagliotti, Maria Pia Brizzi	1
14	Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells? 2022 ·Cancers ·Giuseppe Fanciulli, Roberta Modica, Anna La Salvia, Federica Campolo, Tullio Florio, (unknown), (unknown), (unknown), Annamaria Colao, Antongiulio Faggiano	9
15	Comprehensive Plasma Metabolomic Profile of Patients with Advanced Neuroendocrine Tumors (NETs). Diagnostic and Biological Relevance 2021 ·Cancers ·Beatriz Soldevilla, (unknown), (unknown), (unknown), Ángeles López‐Gonzálvez, Anna La Salvia, (unknown), María Carmen Riesco Martínez, (unknown), Jacinto Sarmentero, (unknown), Raúl Rincón, Coral Barbas, Rocio García‐Carbonero	16
16	Somatostatin Analogue Therapy in MEN1-Related Pancreatic Neuroendocrine Tumors from Evidence to Clinical Practice: A Systematic Review 2021 ·Pharmaceuticals ·Anna La Salvia, Franz Sesti, (unknown), Rossella Mazzilli, Maria Grazia Tarsitano, Elisa Giannetta, Antongiulio Faggiano	7
17	Chemotherapy in NEN: still has a role? 2021 ·Reviews in Endocrine and Metabolic Disorders ·(unknown), Anna La Salvia, María Carmen Riesco Martínez, (unknown), Rocio García‐Carbonero	22
18	Oxidized lipids in the metabolic profiling of neuroendocrine tumors – Analytical challenges and biological implications 2020 ·Journal of Chromatography A ·(unknown), Joanna Godzień, Beatriz Soldevilla, Ana Gradillas, Ángeles López‐Gonzálvez, (unknown), Anna La Salvia, María Carmen Riesco Martínez, Rocio García‐Carbonero, Coral Barbas	14
19	Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018 2020 ·Critical Reviews in Oncology/Hematology ·Pasquale Lombardi, Laura Marandino, Emmanuele De Luca, Clizia Zichi, Maria Lucia Reale, Daniele Pignataro, Rosario Francesco Di Stefano, Eleonora Ghisoni, Annapaola Mariniello, Elena Trevisi, Gianmarco Leone, (unknown), Anna La Salvia, Cristina Sonetto, Francesco Leone, Massimo Aglietta, Silvia Novello, Giorgio V. Scagliotti, Francesco Perrone, Massimo Di Maïo	18
20	Carcinoid heart failure in a duodenal neuroendocrine tumor: role of cardiac surgery in a challenging patient and brief review of the literature 2019 ·Acta Oncologica ·Anna La Salvia, Maria Pia Brizzi, Elena Trevisi, Francesco Parisi, (unknown), (unknown), Massimo Di Maïo, Giorgio V. Scagliotti	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact